91 POSTER Impact of tumor VEGF expression level on the in situ efficacy of the VEGFR2 associated tyrosine kinase inhibitor ZD6474

D.Slemann; C.Norris

首页> 外文期刊>European Journal of Cancer Supplements >91 POSTER Impact of tumor VEGF expression level on the in situ efficacy of the VEGFR2 associated tyrosine kinase inhibitor ZD6474

【24h】

91 POSTER Impact of tumor VEGF expression level on the in situ efficacy of the VEGFR2 associated tyrosine kinase inhibitor ZD6474

机译：91 POSTER肿瘤VEGF表达水平对VEGFR2相关酪氨酸激酶抑制剂ZD6474的原位疗效的影响

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第12期|共2页
作者
D.Slemann; C.Norris;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models [J] . I K Dev, R E Dornsife, T M Hopper, British Journal of Cancer . 2004,第7期

机译：VEGFR2酪氨酸激酶抑制剂的抗肿瘤功效与肿瘤模型中VEGF及其受体VEGFR2的表达有关
2. 107 POSTER Modulatin of the radiation response of zebrafish embryos by targeting the VEGFR2 tyrosine kinase using ZD6474 [J] . G.Kari, A.Y.Zengin, B.Daroczi, European Journal of Cancer Supplements . 2006,第12期

机译：107使用ZD6474靶向VEGFR2酪氨酸激酶的斑马鱼胚胎辐射反应的调制器
3. 606 POSTER Augmented growth inhibition of human NSCLC cells resistant to EGFR-tyrosine kinase inhibitor (TKl) by a combination of dual TKl of EGFR/VEGFR2 (AEE788) and mTOR inhibitor (RAD001) [J] . K.Soejima, I.Nakachi, K.Naoki, European Journal of Cancer Supplements . 2006,第12期

机译：606 POSTER通过双重TK1的EGFR / VEGFR2（AEE788）和mTOR抑制剂（RAD001）的组合增强了对EGFR-酪氨酸激酶抑制剂（TK1）耐药的人NSCLC细胞的生长抑制
4. SHORT-TERM TUMOR RESPONSE TO TYROSINE KINASE INHIBITORS VERSUS LONG-TERM SURVIVAL IN MAST CELL TUMORS: FOLLOW-UP DATA FROM A PIVOTAL FIELD STUDY WITH MASITINIB [C] . Olivier Hermine Annual Conference of the Veterinary Cancer Society . 2009

机译：短期肿瘤对酪氨酸激酶抑制剂的反应与肥大细胞肿瘤的长期存活：来自Masitinib的关键田间研究的后续数据
5. Analysis of pp60c-src and pp62c-yes intracellular protein tyrosine kinase function in colon tumor cell growth regulation using herbimycin A, a tyrosine kinase specific inhibitor. [D] . Garcia, Roy. 1995

机译：使用酪氨酸激酶特异性抑制剂除草霉素A分析pp60c-src和pp62c-yes细胞内蛋白酪氨酸激酶在结肠肿瘤细胞生长调节中的功能。
6. Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models [O] . I K Dev, R E Dornsife, T M Hopper, 2004

机译：VEGFR2酪氨酸激酶抑制剂的抗肿瘤功效与肿瘤模型中VEGF及其受体VEGFR2的表达相关
7. Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models [O] . Dev, I K, Dornsife, R E, Hopper, T M, 2004

机译：VEGFR2酪氨酸激酶抑制剂的抗肿瘤功效与肿瘤模型中VEGF及其受体VEGFR2的表达有关

91 POSTER Impact of tumor VEGF expression level on the in situ efficacy of the VEGFR2 associated tyrosine kinase inhibitor ZD6474

著录项

相似文献

相关主题

期刊订阅